Last reviewed · How we verify

NCT06946719

Octenidine and Sodium Hypochlorite for Pulp Irrigation in Direct Pulp Capping

Active, enrolled NA Last updated 27 April 2025
What this trial tests

NA trial testing pulp lavage Octenidine in Pulp Exposure, Dental in 88 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 June 2024
Primary endpoint
1 December 2024
1 June 2025

Quick facts

Lead sponsorAydin Adnan Menderes University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment88
Start date1 June 2024
Primary completion1 December 2024
Estimated completion1 June 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Aydin Adnan Menderes University

Who can join

Adults 18 to 45, any sex, with Pulp Exposure, Dental. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the included patients, after complete removal of caries from the entire cavity, the exposed pulp will be treated with either a 2.5% NaOCl or 0.1% Octenidine solution. Subsequently, the cavity will be restored using calcium silicate cement, glass ionomer cement, and composite resin. Postoperatively, the patient's pain level will be assessed using the Visual Analogue Scale (VAS) at 24 and 72 hours, as well as on the 7th day. Responses to pulp sensitivity tests and periapical radiographs will be evaluated at 6 months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pulp Exposure, Dental

Currently open trials in the same condition.

Other Aydin Adnan Menderes University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06946719.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing